newsfilter
← Latest News
Business Wire·

VBI Vaccines Announces PreHevbri® is Now Available in the United Kingdom for the Prevention of Hepatitis B in Adults

PreHevbri® is the only approved 3-antigen hepatitis B vaccine for adults in the U.K. Product to be launched via marketing and distribution partner, Valneva VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a